La bourse est fermée
Dow Jones
39 832,29 +274,18 (+0,69 %) Nasdaq
16 727,89 +216,71 (+1,31 %) Nikkei 225
38 385,73 +29,67 (+0,08 %) EUR/USD
1,0883 +0,0061 (+0,57 %) HANG SENG
19 073,71 -41,35 (-0,22 %) Bitcoin EUR
60 167,85 +3 757,43 (+6,66 %)
NanoViricides, Inc. (NNVC)
NYSE American - Nasdaq Cours en temps réel. Devise en USD
Ajouter à la liste dynamique
À partir de 03:08PM EDT. Marché ouvert.
Chargement du graphique interactif...
- ACCESSWIRE
NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun
NanoViricides, Inc. (NYSE American:NNVC) (the "Company") reports that clinical trials of its broad-spectrum antiviral drug NV-CoV-2 began on June 17, 2023 with two oral drug products: (i) NV-CoV-2 Oral Syrup, and (ii) NV-CoV-2 Oral Gummies.
